• This topic has 1 voice and 0 replies.
Viewing 0 reply threads
  • Author
    Posts
    • #13370

      Eloxx Pharmaceuticals will launch a Phase 2 clinical study in the U.S. to test ELX-02 in people with cystic fibrosis who carry the G542X mutation. Read more about it.

      What are your thoughts about this study and its findings?

Viewing 0 reply threads
  • You must be logged in to reply to this topic.
Copyright © 2017-2019 All rights reserved.

©2019 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account